Highlights

  • ECS has signed a Distribution and Manufacturing Agreement with Curaleaf Laboratories.
  • The agreement covers the UK, Channel Islands and Isle of Man.
  • Six ECS-branded Australian-grown medicinal cannabis flower products will launch initially.
  • Supply is targeted for November 2026, subject to regulatory approvals.

ECS Botanics Holdings Ltd (ASX:ECS) announced on 7 October 2026 that it has signed a Distribution and Manufacturing Agreement with Rokshaw Limited, trading as Curaleaf Laboratories. The agreement will bring ECS-branded medicinal cannabis products to the United Kingdom.

Agreement Terms

The agreement covers the United Kingdom, Channel Islands and Isle of Man. It has an initial two-year term with automatic renewal for further two-year periods.

The arrangement is non-exclusive, carries no minimum purchase commitments and operates on a consignment basis, with ECS retaining ownership until product is sold or paid for.

Products and Commercial Structure

Six ECS-branded, Australian-grown medicinal cannabis flower products will launch initially, packed in 10g ECS-branded pouches with UK-compliant labelling. Supply is targeted for November 2026, subject to regulatory approvals.

ECS will supply bulk flower to Curaleaf Laboratories, which will handle local manufacturing, packaging and distribution. ECS will receive an agreed share of the net sales price, giving it direct exposure to UK sell-through.

International Growth Strategy

The UK agreement extends ECS's international branded strategy, following earlier product launches through Nimbus in Germany.

Managing Director Nan-Maree Schoerie said the agreement is another important step in ECS's international growth strategy. Curaleaf International UK Managing Director Jonathan Hodgson said Curaleaf was delighted to partner with ECS Botanics to bring its EU-GMP products to the UK.

Key Takeaways

  • ECS has partnered with Curaleaf Laboratories to enter the UK market.
  • Six branded flower products are set to launch, with supply targeted for November 2026.
  • The non-exclusive, consignment-based deal gives ECS a share of net sales.
  • The UK follows ECS's earlier branded launches in Germany.